Literature DB >> 14607305

Cutaneous silent periods in intramedullary spinal cord lesions.

Markus Kofler1, Martina F Kronenberg, Christian Brenneis, Alexandra Felber, Leopold Saltuari.   

Abstract

OBJECTIVE: The neurophysiological assessment of intramedullary spinal cord lesions has been unsatisfactory. Previous studies in patients with syringomyelia suggest that testing of cutaneous silent periods (CSPs) may be useful to assess centromedullary lesions.
METHODS: The authors studied nine patients with intramedullary spinal cord lesions of different etiologies. Eight patients with cervical lesions presented with hypalgesia, hypothermesthesia, or pain in at least one upper extremity; five of them had also upper limb weakness or sensory impairment. One patient with a thoracic lesion had normal upper limb function. The authors recorded CSPs in abductor pollicis brevis muscle following digit II and digit V stimulation. Somatosensory evoked potentials (SEPs) were obtained following median and tibial nerve stimulation. Motor evoked potentials (MEPs) were obtained in biceps brachii, abductor digiti minimi and tibialis anterior muscles following transcranial magnetic or electrical stimulation.
RESULTS: CSP abnormalities were found in all patients with cervical lesions, but not in the patient with a thoracic lesion. Cortical median nerve SEPs had normal latencies in all patients, while tibial nerve SEPs, upper limb MEPs, and lower limb MEPs were delayed in five patients each. In one patient, abnormal CSP were the only neurophysiological finding. CSP abnormalities were associated with hypalgesia and hypothermesthesia in 95% of the studies.
CONCLUSION: Upper extremity CSP testing is a sensitive neurophysiological technique for the assessment of cervical intramedullary lesions. In particular, abnormal CSPs are highly associated with spinothalamic dysfunction.

Entities:  

Mesh:

Year:  2003        PMID: 14607305     DOI: 10.1016/s0022-510x(03)00211-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Cutaneous silent period in human FDI motor units.

Authors:  Mehmet C Kahya; S Utku Yavuz; Kemal S Türker
Journal:  Exp Brain Res       Date:  2010-08-08       Impact factor: 1.972

2.  Preserved cutaneous silent period in cervical root avulsion.

Authors:  Peter Vasko; Vaclav Bocek; Libor Mencl; Pavel Haninec; Ivana Stetkarova
Journal:  J Spinal Cord Med       Date:  2015-08-27       Impact factor: 1.985

3.  Sensory modulation of voluntary and TMS-induced activation in hand muscles.

Authors:  Markus Kofler; Josep Valls-Solé; Peter Fuhr; Christian Schindler; Barbara R Zaccaria; Leopold Saltuari
Journal:  Exp Brain Res       Date:  2008-04-18       Impact factor: 1.972

4.  Discrepancy between functional recovery and cutaneous silent period change in surgically treated degenerative cervical myelopathy: a prospective pilot study.

Authors:  Nobuaki Tadokoro; Katsuhito Kiyasu; Yusuke Kasai; Motohiro Kawasaki; Ryuichi Takemasa; Masahiko Ikeuchi
Journal:  Spinal Cord       Date:  2019-06-18       Impact factor: 2.772

5.  The cutaneous silent period is preserved in cervical radiculopathy: significance for the diagnosis of cervical myelopathy.

Authors:  A Arturo Leis; Markus Kofler; Ivana Stetkarova; Dobrivoje S Stokic
Journal:  Eur Spine J       Date:  2010-12-05       Impact factor: 3.134

6.  Modulation of the Cutaneous Silent Period in the Upper-Limb with Whole-Body Instability.

Authors:  Nathanial R Eckert; Brach Poston; Zachary A Riley
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

7.  Reversible cutaneous silent period abnormalities in vitamin B12 deficiency: A case report.

Authors:  Elena Fava; Markus Kofler; Leopold Saltuari
Journal:  Clin Neurophysiol Pract       Date:  2019-05-31

Review 8.  Application of electrophysiological measures in degenerative cervical myelopathy.

Authors:  Zhengran Yu; Wenxu Pan; Jiacheng Chen; Xinsheng Peng; Zemin Ling; Xuenong Zou
Journal:  Front Cell Dev Biol       Date:  2022-08-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.